Dados B3 › RCSL3 × VAMO3
RCSL3 × VAMO3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | RCSL3 | VAMO3 | year |
|---|---|---|---|
| ROE | — | 0.0% | no year where both have it |
| ROIC | — | 13.8% | no year where both have it |
| ROA | -42.7% | 1.5% | 2025 |
| Gross margin | 15.5% | 52.4% | 2025 |
| EBIT margin | -658.3%! | 45.4% | 2025 |
| Net margin | -1,077.1% | 5.7% | 2025 |
| Net debt/EBITDA | -0.19x | 2.98x | 2022 |
| Current ratio | 0.63x | 1.81x | 2025 |
| Revenue growth (1y) | -92.1% | 22.5% | 2025 |
| Revenue growth (5y CAGR) | -44.0% | 30.6% | 2025 |
| Piotroski F-Score | 2/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | RCSL3 | VAMO3 | year |
|---|---|---|---|
| P/E | -0.01x | — | 2025 |
| P/B | — | 1.55x | 2025 |
| EV/EBITDA | — | 4.37x | 2025 |
| FCF yield | — | -23.1% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:37 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:37 UTC. If this does not match /saude, you are reading a cached copy.